Kitamura Shinji, Maeshima Yohei, Sugaya Takeshi, Sugiyama Hitoshi, Yamasaki Yasushi, Makino Hirofumi
Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
Nephron Exp Nephrol. 2003;95(2):e79-86. doi: 10.1159/000073675.
Vascular endothelial growth factor (VEGF) is a potent endothelial cell mitogen that promotes angiogenesis, vasculogenesis, and increases vascular permeability. VEGF is expressed in renal tubular epithelial cells and urinary VEGF excretion is increased in various glomerular disorders. However, the mechanisms underlying expression of VEGF in renal tubular epithelial cells have not been fully elucidated. In the present study, we attempted to define a predominant regulator of VEGF expression using a cultured murine renal proximal tubular epithelial cell line (mProx24). VEGF protein concentration in the culture supernatant was measured by sandwich enzyme-linked immunosorbent assay. mProx24 constitutively produced VEGF at low level. Major isoforms expressed in this cell line were VEGF164 and VEGF120 determined by reverse transcription-polymerase chain reaction method. Among various stimuli including angiotensin II, transforming growth factor-beta1 (TGF-beta1), lipopolysaccharides, interleukin-1beta, interleukin-10 and interferon-gamma, only TGF-beta1 significantly increased the level of VEGF protein at 24 h in a dose-dependent manner. The steady-state mRNA level of VEGF was dose dependently increased by TGF-beta1 detected by Northern blotting. Treatment with neutralizing anti-TGF-beta1 antibody abolished TGF-beta1-induced VEGF expression by 70%. Inhibitors of protein kinase C (PKC), Ro-31-8220 and staurosporin, significantly suppressed TGF-beta1-induced VEGF protein expression. These results demonstrate the role of TGF-beta1 on the expression of VEGF in proximal tubular epithelial cells mediated potentially via PKC pathway. This regulatory mechanism may be associated with the progression of tubulointerstitial lesions in renal disorders.
血管内皮生长因子(VEGF)是一种强效的内皮细胞有丝分裂原,可促进血管生成、血管发生并增加血管通透性。VEGF在肾小管上皮细胞中表达,并且在各种肾小球疾病中尿VEGF排泄增加。然而,VEGF在肾小管上皮细胞中表达的潜在机制尚未完全阐明。在本研究中,我们试图使用培养的小鼠肾近端肾小管上皮细胞系(mProx24)来确定VEGF表达的主要调节因子。通过夹心酶联免疫吸附测定法测量培养上清液中的VEGF蛋白浓度。mProx24组成性地以低水平产生VEGF。通过逆转录-聚合酶链反应法确定,该细胞系中表达的主要异构体是VEGF164和VEGF120。在包括血管紧张素II、转化生长因子-β1(TGF-β1)、脂多糖、白细胞介素-1β、白细胞介素-10和干扰素-γ在内的各种刺激中,只有TGF-β1在24小时时以剂量依赖性方式显著增加VEGF蛋白水平。通过Northern印迹检测,TGF-β1使VEGF的稳态mRNA水平呈剂量依赖性增加。用中和抗TGF-β1抗体处理可消除TGF-β1诱导的VEGF表达的70%。蛋白激酶C(PKC)抑制剂Ro-31-8220和星形孢菌素显著抑制TGF-β1诱导的VEGF蛋白表达。这些结果证明了TGF-β1在近端肾小管上皮细胞中VEGF表达上的作用,可能是通过PKC途径介导的。这种调节机制可能与肾脏疾病中肾小管间质病变的进展有关。